Cardio-oncology & other

Cardiac mechanics in response to proteasome inhibition: a prospective study

Eur Heart J Cardiovasc ImagingPublished Prospective cohort study

Authors' conclusion

Inhibition of the UPS induced global deterioration of cardiac function.

Study context

Population
Patients with multiple myeloma receiving carfilzomib (irreversible proteasome inhibitor, Kd protocol)
Participants
48 patients
Outcome
Cardiac mechanics (echocardiography with speckle tracking)
Follow-up
3 and 6 months

Main finding

As reported in the abstract

At 6 months: Left ventricular (LV) and RV functions additionally attenuated
P < 0.05 for all
Changes in proteasome activity associated with changes in global longitudinal strain (GLS), segmental LV strain and left atrial (LA) markers
P < 0.05 for all

Observational data: associations, not effects.

Further findings

Baseline GLS < −18% or LA strain rate > 1.71 associated with null hypertension events

Original publication

Cardiac mechanics in response to proteasome inhibition: a prospective study. Eur Heart J Cardiovasc Imaging. Published 18 August 2022. doi:10.1093/ehjci/jeac168

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.